Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Professor Goldsteins research contributions include: Co-discovery and isolation of the thymosin family of peptides in the 1960s First clinical trials of thymosin preparations in immunodeficient children (1974) Characterization of thymosin beta-4s actin-binding and wound healing properties Development of therapeutic applications for tissue repair and regeneration Over 450 published scientific articles and 25+ patents related to thymosins Leadership in translating thymosin research toward clinical development Disclaimer: This spotlight is provided for educational purposes to acknowledge scientific contributions to BPC-157 and TB-500/thymosin beta-4 research
T.LevinS
Wyatt also recommended leveraging purchase-based targeting to personalize the messaging for each type of GLP-1 user, as each demographic has its own unique needs
The company is studying the drug in a Phase 1 clinical study titled "A Randomized, Double-Blind, Placebo and Comparator-Controlled Crossover Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes"
Treatment recommendations vary and depend on provider evaluation
US$ 21.23
US$ 26.96
US$ 24.90
US$ 29.10
US$ 25.31
US$ 21.06
.png)
